View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Ruxolitinib cream for Vitiligo

Phase: III
Clinicaltrials.gov ID: NCT06548360

What is the goal of the study?

Randomized, double-blind, vehicle-controlled study with an openlabel, treatment-extension period. Studying the Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Anna Garza-Mayers
Study Team Member: Jacqueline Lee-Eng, jacqueline.lee-eng@seattlechildrens.org